drugset / Trial / NCT01936233

Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery

NCT01936233

Phase 3 Unknown 112 enrolled Fudan University
RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluation the Treatment Outcome of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery.

Timeline

Start
2013-08
Primary completion
2021-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 0.1 unknown Oral
Subject Lamivudine Other / unclassified 0.1 unknown Oral